Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT00403806 Terminated - Postoperative Pain Clinical Trials

Dexamethasone for Paediatric Adeno-tonsillectomy - A Dose-finding Study

Start date: February 2005
Phase: Phase 4
Study type: Interventional

Adeno-tonsillectomy is a commonly performed surgical procedure in children. Main morbidities are postoperative pain, nausea and vomiting, and haemorrhage. Non-steroidal anti-inflammatory drugs (NSAIDs)widely used for paincontrol increase the risk of postoperative bleeding and reoperation. Dexamethasone is an powerful antiemetic and has shown analgesic efficacy. Antiemetic and analgesic dose-response has never been established.

NCT ID: NCT00398528 Terminated - Clinical trials for Relapsing-Remitting Multiple Sclerosis

An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis

Start date: September 2006
Phase: Phase 4
Study type: Observational

Impaired short term memory, attention and concentration lapses, and slower processing of information occur in up to 40-65% of patients with Multiple Sclerosis (MS). The quality of life of individuals with MS is impacted to the degree with which they experience these symptoms. There are several medications approved by the United States Food and Drug Administration (FDA) to treat MS symptoms and to modify (slow) disease course. Traditional approaches to determining the effectiveness of medications used in treating MS rely on reports of the number of relapses an individual experiences, as well as standard clinical tests, such as the Kurtzke Expanded Disability Status Scale (EDSS). This research study will look at whether the functional magnetic resonance imaging (fMRI) scan can be used as a tool for measuring changes in the brain associated with treatment in MS patients. Unlike a typical MRI which provides structural information about the brain, the fMRI provides information about brain activity during performance of cognitive or motor tasks.

NCT ID: NCT00394485 Terminated - Clinical trials for Pulmonary Disease, Chronic Obstructive

Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients

Start date: May 2006
Phase: Phase 4
Study type: Interventional

Study compares the efficacy and safety of tiotropium + a beta agonist (procaterol) vs. tiotropium alone among patients with moderate chronic obstructive pulmonary disease

NCT ID: NCT00387426 Terminated - Clinical trials for Chronic Myelomonocytic Leukemia

Sunitinib in Treating Patients With Idiopathic Myelofibrosis

Start date: September 2006
Phase: Phase 2
Study type: Interventional

This phase II trial is studying how well sunitinib works in treating patients with idiopathic myelofibrosis. Sunitinib may stop the growth of abnormal cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the abnormal cells.

NCT ID: NCT00384891 Terminated - Neoplasms Clinical Trials

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Start date: February 2002
Phase: Phase 3
Study type: Interventional

The study is designed to compare the efficacy and safety of 2 treatment types for the prevention of tumor recurrence of superficial bladder cancer: 1. A combination of bladder wall heating and local chemotherapy (Synergo) 2. Bacillus Calmette-Guérin (BCG)

NCT ID: NCT00383565 Terminated - Clinical trials for Recurrent Mantle Cell Lymphoma

FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Start date: September 2006
Phase: Phase 2
Study type: Interventional

FR901228 may stop the growth of cancer cells by blocking some of the enzymes needed for cell to grow and by blocking blood flow to the cancer. This phase II trial is studying how well FR901228 works in treating patients with relapsed or refractory non-Hodgkin's lymphoma.

NCT ID: NCT00381693 Terminated - Clinical trials for Chronic Myeloproliferative Disorders

Azacitidine in Treating Patients With Myelofibrosis

Start date: August 2006
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of abnormal cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well azacitidine works in treating patients with myelofibrosis.

NCT ID: NCT00378885 Terminated - Clinical trials for Sexual Risk Behavior for HIV-Infection

Effect Study of a Theory-Based Internet Intervention on Safe-Sex Practices

Start date: January 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the efficacy of a theory based, online tailored intervention on stimulating safe-sex practices among men who have sex with men (MSM). Our hypothesis was that a tailored internet intervention would be more effective in stimulating safe-sex practices of gay men than a non-tailored internet intervention when compared to a waiting-list control group.

NCT ID: NCT00377247 Terminated - Clinical trials for Squamous Cell Carcinoma of the Head and Neck

Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor

Start date: April 2009
Phase: Phase 1
Study type: Interventional

The primary goal of this study is to determine if the vaccine can be safely given to subjects, and to see what side effects occur (both good and bad) when they are given this experimental tumor vaccine. During this study, investigators intend to watch for tumor response while examining the effects of this vaccine on the body's immune system after it is given.

NCT ID: NCT00377104 Terminated - Clinical trials for B-cell Chronic Lymphocytic Leukemia

Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Start date: September 2006
Phase: Phase 1
Study type: Interventional

This phase I trial is studying the side effects and best dose of flavopiridol in treating patients with B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma. Drugs used in chemotherapy, such as alvocidib, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.